Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. ADR (NQ: SNY )

48.69 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,694
Open 48.69
Bid (Size) 48.71 (2)
Ask (Size) 48.79 (10)
Prev. Close 48.69
Today's Range 48.69 - 48.69
52wk Range 42.63 - 55.72
Shares Outstanding 1,250,690,553
Dividend Yield 3.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
Novavax strikes co-exclusive licensing deal with Sanofi (SNY) for COVID-19 and flu-COVID-19 vaccines. Terms include upfront payment of $500M, milestone opportunities, and revenue guidance update. 
Via Benzinga
Exposures COVID-19
Why Is Novavax (NVAX) Stock Up 118% Today?
Novavax stock is up on Friday after the vaccine company announced a licensing agreement with Sanofi as its Q1 earnings report. 
Via InvestorPlace

Performance

YTD
-2.62%
-2.62%
1 Month
+2.44%
+2.44%
3 Month
+4.57%
+4.57%
6 Month
+7.08%
+7.08%
1 Year
-10.78%
-10.78%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
3 Biotech Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Via Benzinga
Topics Stocks
Exposures US Equities
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
Via InvestorPlace
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Via The Motley Fool
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation
Via Benzinga
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Via The Motley Fool
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024
From Pinnacle Group International
Via ACN Newswire
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
Via Talk Markets
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Via Benzinga
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Sanofi Reports Strong Earnings, Joins Kirby, Sonic Automotive, Union Pacific And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings
Via Benzinga
SNY Stock Earnings: Sanofi Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags
Via Investor's Business Daily
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
Via Benzinga
Novartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Years
Via Benzinga
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
Via Benzinga
Sanofi's Multiple Sclerosis Antibody Shows Reduction Of Disease Activity
Via Benzinga
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Via Benzinga
Novo Nordisk Arms Wegovy to Be a Triple Threat
Via MarketBeat
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.